Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Relevant Financial Activities Outside the Submitted Work Peter D. Siersema is receiving research support from Pentax (Japan), The eNose Company, MicroTech (China), and Motus GI (USA). Rob H.A. Verhoeven has received research grants from Bristol Myers Squibb and Roche. Emma C. Gertsen, Arjen van der Veen, Hylke J.F. Brenkman, Lodewijk A.A. Brosens, Rachel S. van der Post, Josianne C.H.B.M. Luijten, Pauline A.J. Vissers, Erik Vegt, Richard van Hillegersberg, and Jelle P. Ruurda have no disclosures to declare in relation to this work.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Gertsen, E.C., van der Veen, A., Brenkman, H.J.F. et al. ASO Visual Abstract: Multimodal Therapy Versus Primary Surgery for Gastric and Gastroesophageal Junction Diffuse Type Carcinoma, with a Focus on Signet Ring Cell Carcinoma: A Nationwide Study. Ann Surg Oncol 31, 3034–3035 (2024). https://doi.org/10.1245/s10434-023-14865-7
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-023-14865-7